01707nam a22003377a 4500
170804s20172017 xxu||||| |||| 00| 0 eng d
0960-3271
Ovid MEDLINE(R)
28764574
Designer drugs: Review and implications for emergency management.
Human & Experimental Toxicology. 37(1):94-101, 2018 Jan.
Hum Exp Toxicol. 37(1):94-101, 2018 Jan.
Human & experimental toxicology
2018
FY2018
2017-08-04
In the past 10 years, "designer drugs" such as synthetic cannabinoids and cathinones have emerged and come into widespread use, resulting in more overdose cases involving these new drugs in the United States. Emergency departments regularly treat a diverse array of drug intoxications, and providers must be cognizant of novel drugs of abuse and the associated clinical presentations in order to provide the most appropriate care. This review aims to describe the epidemiology, mechanism of action, clinical presentation, and treatment of intoxication for both the common and newest drugs of abuse.
English
*Designer Drugs/ae [Adverse Effects]
*Drug Overdose/dt [Drug Therapy]
Emergencies
Humans
MedStar Washington Hospital Center
Emergency Medicine
Journal Article
NEED CITATION
Mazer-Amirshahi, Maryann
Chistov S, Li A, Mazer-Amirshahi M, Park M, Pourmand A
https://dx.doi.org/10.1177/0960327117698542
https://dx.doi.org/10.1177/0960327117698542
ART
Article
0
0
0
0
Article
authcat
authcat
2017-08-04
0
28764574
28764574
2017-08-04
2017-08-04
ART
2550
2550